跳至主要内容
临床试验/JPRN-jRCT1080223307
JPRN-jRCT1080223307招募中3 期

Efficacy and Safety Study of Autologous Cardiac Stem Cells (JRM- 001) Treated After Reconstructive Surgery in Pediatric Patients With Congenital Heart Disease

Metcela Inc.0 个研究点目标入组 40 人开始时间: 2016年8月30日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
Metcela Inc.
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 <= 6age old(—)
性别
All

入选标准

  • Main inclusion criteria:
  • - Functional single ventricle patient who is scheduled for stage 2 (Glenn) or stage 3 (Fontan) surgery
  • - Ejection fraction (%) by echocardiography =< 55%

排除标准

  • Main exclusion criteria:
  • - Known medical history of cardiogenic shock
  • - Lethal, uncontrollable arrhythmia
  • - Complication of coronary artery disease
  • - Eisenmenger syndrome
  • - Complication of brain dysfunction due to circulatory failure
  • - Malignant neoplasm
  • - Complication of severe neurologic disorder
  • - Severe pulmonary embolism or pulmonary hypertension
  • - Severe renal failure
  • - Multiple organ failure
  • - Active infection (including endocarditis)
  • - Active hemorrhagic disease (e.g. gastrointestinal bleeding, injury)

研究者

发起方
Metcela Inc.

相似试验